270 related articles for article (PubMed ID: 23924605)
1. The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression.
Sadakierska-Chudy A; Haduch A; Rysz M; Gołembiowska K; Daniel WA
Biochem Pharmacol; 2013 Sep; 86(6):800-7. PubMed ID: 23924605
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
Bromek E; Wójcikowski J; Daniel WA
Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 is regulated by noradrenergic and serotonergic systems.
Kot M; Daniel WA
Pharmacol Res; 2011 Oct; 64(4):371-80. PubMed ID: 21742037
[TBL] [Abstract][Full Text] [Related]
4. The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity.
Kot M; Sadakierska-Chudy A; Haduch A; Rysz M; Bromek E; Gołembiowska K; Daniel WA
Eur J Pharmacol; 2015 Mar; 751():34-41. PubMed ID: 25637782
[TBL] [Abstract][Full Text] [Related]
5. Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450.
Rysz M; Bromek E; Haduch A; Sadakierska-Chudy A; Daniel WA
Drug Metab Dispos; 2015 Sep; 43(9):1345-52. PubMed ID: 26059263
[TBL] [Abstract][Full Text] [Related]
6. Activation of brain serotonergic system by repeated intracerebral administration of 5-hydroxytryptophan (5-HTP) decreases the expression and activity of liver cytochrome P450.
Rysz M; Bromek E; Daniel WA
Biochem Pharmacol; 2016 Jan; 99():113-22. PubMed ID: 26581122
[TBL] [Abstract][Full Text] [Related]
7. The nuclear receptors pregnane X receptor and constitutive androstane receptor contribute to the impact of fipronil on hepatic gene expression linked to thyroid hormone metabolism.
Roques BB; Leghait J; Lacroix MZ; Lasserre F; Pineau T; Viguié C; Martin PG
Biochem Pharmacol; 2013 Oct; 86(7):997-1039. PubMed ID: 23962444
[TBL] [Abstract][Full Text] [Related]
8. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications.
Wójcikowski J; Gołembiowska K; Daniel WA
Biochem Pharmacol; 2008 Jul; 76(2):258-67. PubMed ID: 18538745
[TBL] [Abstract][Full Text] [Related]
9. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat.
Wójcikowski J; Daniel WA
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):631-45. PubMed ID: 19442036
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of endobiotic-oxidizing cytochromes P450 in vitamin A-deficient male rat liver.
Murray M; Sefton RM; Croft KD; Butler AM
Br J Pharmacol; 2001 Dec; 134(7):1487-97. PubMed ID: 11724755
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet.
Kot M; Pilc A; Daniel WA
Pharmacol Res; 2012 Oct; 66(4):292-9. PubMed ID: 22749902
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms.
Danek PJ; Bromek E; Daniel WA
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209648
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Receptors of 5-HT
Bromek E; Rysz M; Haduch A; Daniel WA
Drug Metab Dispos; 2019 Feb; 47(2):80-85. PubMed ID: 30518657
[TBL] [Abstract][Full Text] [Related]
14. The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.
Bromek E; Danek PJ; Wójcikowski J; Basińska-Ziobroń A; Pukło R; Solich J; Dziedzicka-Wasylewska M; Daniel WA
Pharmacol Rep; 2022 Oct; 74(5):1107-1114. PubMed ID: 36018449
[TBL] [Abstract][Full Text] [Related]
15. Regulation of constitutive mouse hepatic cytochromes P450 and growth hormone signaling components by 3-methylcholanthrene.
Lee C; Hutson JR; Tzau VK; Riddick DS
Drug Metab Dispos; 2006 Sep; 34(9):1530-8. PubMed ID: 16782765
[TBL] [Abstract][Full Text] [Related]
16. The role of the nervous system in the regulation of liver cytochrome p450.
Wójcikowski J; Daniel WA
Curr Drug Metab; 2011 Feb; 12(2):124-38. PubMed ID: 21401511
[TBL] [Abstract][Full Text] [Related]
17. Identification of factors mediating the effect of the brain dopaminergic system on the expression of cytochrome P450 in the liver.
Wójcikowski J; Daniel WA
Pharmacol Rep; 2008; 60(6):966-71. PubMed ID: 19211990
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels.
Lu SK; Callahan SM; Brunner LJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):331-7. PubMed ID: 12649386
[TBL] [Abstract][Full Text] [Related]
19. The reverse role of the hypothalamic paraventricular (PVN) and arcuate (ARC) nuclei in the central serotonergic regulation of the liver cytochrome P450 isoform CYP2C11.
Rysz M; Bromek E; Haduch A; Liskova B; Wójcikowski J; Daniel WA
Biochem Pharmacol; 2016 Jul; 112():82-9. PubMed ID: 27137992
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms.
Danek PJ; Kuban W; Daniel WA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]